Cell-free systems enable in vitro biosynthesis by reconstituting metabolic pathways outside living cells. The abstract presents them as platforms for producing industrial chemicals, biofuels, pharmaceutical precursors, and specialty compounds.
First-pass extracted concept
cell-free systems
Candidate: concept label8 source documents30 linked claims
Live refresh every 5sNext refresh in 5s
Aliases
CFS, CFSs
Extracted Explainers
What the tool is doing
Resources required
What problem it solves
What it does not solve
Evidence Snippets
Cell-free systems let researchers carry out biological processes like protein synthesis and metabolism without using living cells.
We also present a pragmatic framework for the rational application of state-of-the-art tools, including cell-free systems, synthetic microbial consortia, hybrid chemoenzymatic synthesis, and machine learning, to sustainably produce paclitaxel and other natural products.
Cell-free systems (CFSs) have become powerful tools in synthetic biology.
Cell-free systems have also become a revolutionary platform for low-cost diagnostics, providing fast, flexible, and scalable solutions to the conventional cell-based assays.
the different categories of cell-free systems, like enzyme-based (PURE systems), lysate-based (TX-TL), and hybrid systems
Cell-free systems (CFS) are in vitro technologies (outside living cells) that use cellular components to reproduce cellular processes outside living organisms, such as protein synthesis, gene expression, and metabolic reactions.
Cell-free systems (CFS) decouple gene expression and metabolic pathways from living cells, offering a rapid, modular platform for biosensing, pathway prototyping, and protein production.
The applications of cell-free systems, modular genetic circuits, and nanomaterial-enhanced platforms have further expanded the versatility of these tools, which include infectious disease diagnostics, public health monitoring, and food safety.
Supporting Sources
Linked Claims
Computational approaches for cell-free systems are discussed in applications including paper-based diagnostics, reconstructed metabolic pathways, and high-yield cell-free protein synthesis.
Quoted textsource-backed
We summarize key software and discuss applications in paper-based diagnostics, reconstructed metabolic pathways, and high-yield cell-free protein synthesis.
Cell-free systems have been useful in point-of-care diagnostics, particularly in resource-poor environments.
Quoted textsource-backed
Such systems... have been of great use in point-of-care (POC) diagnostics, particularly in resource-poor environments.
AI methods are being used with cell-free systems to predict experimental outcomes, design new proteins, and identify improved reaction conditions.
Bayesian optimization and neural networks have been used to streamline metabolic pathway design, enzyme engineering, and yield prediction in cell-free-related workflows.
Cell-free systems are used to prepare industrial chemicals, biofuels, pharmaceutical precursors, and specialty compounds.
In the medical field, cell-free systems are widely applied in vaccine production, gene expression research, and point-of-care diagnostics.
Cell-free systems decouple gene expression and metabolic pathways from living cells and provide a rapid, modular platform for biosensing, pathway prototyping, and protein production.
Quoted textsource-backed
Cell-free systems (CFS) decouple gene expression and metabolic pathways from living cells, offering a rapid, modular platform for biosensing, pathway prototyping, and protein production.
Cell-free systems enable fast, modular, and customizable biosensors without relying on living cells.
Cell-free systems enable rapid testing, parallel experimentation, and tight control of reaction conditions for biological processes without living cells.
Cell-free systems permit reconstitution of metabolic pathways with purified enzymes or crude lysates, enabling rapid prototyping, precise control of reaction conditions, and increased production of target compounds.
Cell-free systems are described as a platform for low-cost diagnostics that provides fast, flexible, and scalable alternatives to conventional cell-based assays.
Quoted textsource-backed
Cell-free systems have also become a revolutionary platform for low-cost diagnostics, providing fast, flexible, and scalable solutions to the conventional cell-based assays.
Reagent stability, scalability, and regulatory implications are major challenges for cell-free diagnostic development.
Quoted textsource-backed
Major challenges in the form of reagent stability, scalability, and regulatory implications are analyzed carefully...
Cell-free systems are in vitro technologies that use cellular components to reproduce cellular processes outside living organisms, including protein synthesis, gene expression, and metabolic reactions.
The paper presents a pragmatic framework for rational application of cell-free systems, synthetic microbial consortia, hybrid chemoenzymatic synthesis, and machine learning to sustainable paclitaxel and natural product production.
Cell-free system categories are used to emphasize modular pathway construction, cofactor balancing, and energy regeneration.
The combination of AI and cell-free systems may enable digital twins and self-driven biomanufacturing units.
Cell-free systems open new opportunities and have large near-future potential in next-generation synthetic biology.
Current AI and cell-free integration faces hurdles including data requirements, model transferability, and scalability.
Current gaps in computational biology for cell-free systems include limited standardization of kinetic assays, sparse public datasets, and few hybrid kinetic-constraint modeling studies.
Quoted textsource-backed
Finally, we identify current gaps limited standardization of kinetic assays, sparse public datasets, and few hybrids kinetic-constraint modeling studies
Despite significant benefits, cell-free systems still face technological challenges and scientific limitations.
Synthetic biology offers substantial opportunities for de novo paclitaxel production, especially after recent advances in elucidating its biosynthetic pathways.
Active-learning-guided buffer optimization produced a 34-fold increase in protein yield in a cell-free context.
Optimization of cell-free systems is difficult because many variables interact unpredictably.
Paclitaxel supply remains persistently challenging for sustainable production.
Synthetic biology tools, system engineering strategies, and scale-up techniques contribute to productivity and reduce production costs in cell-free chemical production.
The review proposes community resources and hybrid modeling efforts that combine mechanistic clarity with machine-learning-driven speed for cell-free systems.
Quoted textsource-backed
propose a roadmap for community resources and hybrid modeling efforts that combine mechanistic clarity with machine learning (ML)-driven speed
The chapter categorizes cell-free systems into enzyme-based PURE systems, lysate-based TX-TL systems, and hybrid systems.
AI-based system design and personalization of diagnostics are presented as recent trends in the cell-free diagnostics area.
Quoted textsource-backed
Major challenges... are analyzed carefully along with recent trends such as AI-based system design and personalization of diagnostics.
Cell-free systems are considered useful tools for exploring and illustrating fundamental principles of biological systems.
Cell-free systems, modular genetic circuits, and nanomaterial-enhanced platforms are described as expanding the versatility of synthetic biology diagnostic tools for infectious disease diagnostics, public health monitoring, and food safety.